Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI
Emily Seale, Maria Ochoa Molina, Sasha Carsen, Holden Sheffield, Khaldoun Koujok, Marie‐Eve Robinson, Janusz Feber, Kevin Smit, Marika Pagé, Scott E. Walker, Nasrin Khan, Victor N. Konji, Frank Rauch, Leanne M. Ward
Topics & Concepts
DenosumabOsteogenesis imperfectaMedicineOsteomalaciaInternal medicineZoledronic acidEndocrinologyCalcium metabolismParathyroid hormoneOsteoporosisCreatinineCalciumUrologyPathologyConnective tissue disorders researchBone health and treatmentsVitamin K Research Studies